COVID-19大流行对系统性硬化症患者肺动脉高压的医疗可及性与诊断的影响
该研究调查了澳大利亚硬皮病队列中南澳大利亚和维多利亚州共312例系统性硬化症患者,评估COVID-19限制对医疗可及性和肺动脉高压筛查的影响。维多利亚州受访者较南澳大利亚州报告更少的风湿科就诊机会、更多的视频问诊和医疗中断、更差的心理健康。2020至2022年年度访视、肺功能检查、经胸超声心动图和肺动脉高压新诊断均较2011至2019年减少。
要点
- 维多利亚州受访者较南澳大利亚州报告风湿科就诊机会减少(49.3% vs 27.9%)。
- 受访者报告肺功能检查和经胸超声心动图的可及性分别降低31.7%和22.5%。
- 2020至2022年年度访视、肺功能检查、经胸超声心动图和肺动脉高压新诊断较2011至2019年减少。
核心结论
- COVID-19大流行相关的医疗服务中断与系统性硬化症患者心理健康更差以及肺动脉高压筛查和诊断减少相关,可能影响长期结局。
研究设计与样本
- 基于澳大利亚硬皮病队列研究,对南澳大利亚和维多利亚州入组的系统性硬化症患者进行问卷调查,比较疫情前後年度风湿科评估、肺功能检查和经胸超声心动图筛查肺动脉高压的频率。
- 共810例患者中312例应答(应答率38.5%),其中女性273例(87.5%),中位年龄64.7岁,77.2%为局限型疾病,中位病程15.6年,15.7%接受免疫抑制治疗,32.1%有间质性肺病,6.4%有肺动脉高压。
主要发现
- 65.7%的诊疗为远程医疗,其中81.2%通过电话进行。
- 与南澳大利亚州受访者(n=109)相比,经历长时间封锁的维多利亚州受访者(n=203)报告风湿科就诊机会减少(49.3% vs 27.9%;P=0.004)、视频问诊使用更多(17.3% vs 2.1%;P=0.008)、医疗中断更多(49.0% vs 23.2%;P<0.001)以及心理健康更差(P=0.002)。
- 受访者报告肺功能检查和经胸超声心动图的可及性分别降低31.7%和22.5%。
- 2020至2022年年度访视、肺功能检查、经胸超声心动图和肺动脉高压新诊断较2011至2019年减少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Regular clinical assessment for complications of systemic sclerosis (SSc) such as pulmonary arterial hypertension (PAH) is essential for early institution of therapy and improved outcomes. The objective of this study was to determine the impact of COVID-19 pandemic-related restrictions on health care access of patients with SSc, including screening for PAH. METHODS: South Australian and Victorian patients enrolled in the Australian Scleroderma Cohort Study were surveyed about their perceptions of the impact of the pandemic on mental well-being, access to medications, investigations, and management of SSc. Frequency of annual rheumatology assessments, pulmonary function tests (PFT), and transthoracic echocardiography (TTE) to screen for PAH were compared with rates from before the pandemic. RESULTS: A total of 312 of 810 patients with SSc responded (38.5% response); 273 were female (87.5%), the median age was 64.7 years, 77.2% had limited disease, the median illness duration was 15.6 years, 15.7% were immunosuppressed, 32.1% had interstitial lung disease, and 6.4% had PAH. A total of 65.7% of consultations were by telehealth, of which 81.2% were by telephone. Compared with respondents in South Australia (n = 109), Victorian respondents (n = 203) experiencing prolonged lockdown, reported reduced access to their rheumatologist (49.3% vs 27.9%; P = 0.004), greater use of consultation by video (17.3% vs 2.1%; P = 0.008), greater health care disruption (49.0% vs 23.2%; P < 0.001), and worse mental health (P = 0.002). Respondents reported reduced access to PFT and TTE (31.7% and 22.5%, respectively). Annual visits, PFT, TTE, and new diagnoses of PAH were reduced in 2020 to 2022 compared with 2011 to 2019. CONCLUSION: The COVID-19 pandemic-related disruption to health care for patients with SSc was associated with worse mental health and reduced screening and diagnosis of PAH, which may impact long-term outcomes.
引用
- Callisto A, Hansen D, Walker J, et al. Impact of the COVID-19 Pandemic on Health Care Access and Diagnosis of Pulmonary Arterial Hypertension Among Patients With Systemic Sclerosis. Arthritis Care Res (Hoboken). 2023. PMID: 37728139. doi:10.1002/acr.25239
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。